| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $18.6M | +5.3% |
| SG&A Expense | $20.6M | -68.4% |
| Operating Income | -$39.7M | +51.5% |
| Interest Expense | $5.8M | -20.0% |
| Income Tax | $0 | — |
| Net Income | -$42.2M | +5.9% |
| EPS (Basic) | -$17.35 | +41.1% |
| EPS (Diluted) | -$17.35 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.9M | -27.8% |
| Current Assets | $52.9M | -38.5% |
| Total Assets | $55.9M | -35.6% |
| Current Liabilities | $8.3M | -67.5% |
| Long-term Debt | $34.2M | -21.0% |
| Total Liabilities | $48.4M | -28.6% |
| Stockholders' Equity | $7.5M | -60.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.9M | +64.6% |
| Investing Cash Flow | -$429K | -100.7% |
| Financing Cash Flow | $8.5M | +207.1% |
| +41.1% |